Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

Aims: Natural fungal products were screened for antifungal compounds. The mode of action of one of the hits found and the taxonomy of the producing organism were analysed.

[1]  J. Bissett.  Notes on Tolypocladium and related genera , 1983 .

[2]  J. Bissett.  A revision of the genus Trichoderma. II: Infrageneric classification , 1991 .

[3]  J. A. Gorman,et al.  Ascosteroside, a new antifungal agent from Ascotricha amphitricha. I. Taxonomy, fermentation and biological activities. , 1996, The Journal of antibiotics.

[4]  J. Onishi,et al.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase , 1994, Antimicrobial Agents and Chemotherapy.

[5]  R. Schwartz,et al.  The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms. , 2000, Systematic and applied microbiology.

[6]  R. Schwartz,et al.  Discovery of Novel Antifungal (1,3)-β-d-Glucan Synthase Inhibitors , 2000, Antimicrobial Agents and Chemotherapy.

[7]  J. Bissett.  A revision of the genus Trichoderma. I. Section Longibrachiatum sect. nov. , 1984 .

[8]  D. Schmatz,et al.  In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin , 1992, Antimicrobial Agents and Chemotherapy.

[9]  B. Gazzard,et al.  Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis , 1997, AIDS.

[10]  J. Bissett.  A revision of the genus Trichoderma. IV. Additional notes on section Longibrachiatum , 1991 .

[11]  H. Reichenbach,et al.  Isolierung und Strukturaufklärung von Ergokonin A und B: zwei neue antifungische Sterol-Antibiotika aus Trichoderma koningii , 1991 .

[12]  C. Douglas,et al.  Lipopeptide inhibitors of fungal glucan synthase. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[13]  J. Karlowsky,et al.  In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species , 1997, Antimicrobial agents and chemotherapy.

[14]  M. Pfaller,et al.  In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. , 1998, Diagnostic microbiology and infectious disease.

[15]  C. Kubicek,et al.  REVISION OF TRICHODERMA SECT. LONGIBRACHIATUM INCLUDING RELATED TELEOMORPHS BASED ON ANALYSIS OF RIBOSOMAL DNA INTERNAL TRANSCRIBED SPACER SEQUENCES , 1997 .

[16]  R. Schwartz,et al.  Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms , 2001, International microbiology : the official journal of the Spanish Society for Microbiology.

[17]  G. Samuels.  The hypocrea schweinitzii complex and trichoderma sect. longibrachiatum , 1998 .

[18]  W. Turner,et al.  ECHINOCANDIN ANTIFUNGAL AGENTS , 1997 .

[19]  R. Stratford,et al.  Development of a plasma high-performance liquid chromatographic assay for LY303366, a lipopeptide antifungal agent, and its application in a dog pharmacokinetic study. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[20]  S. Klohr,et al.  Ascosteroside, a new antifungal agent from Ascotricha amphitricha. II. Isolation and structure elucidation. , 1996, The Journal of antibiotics.

[21]  I..,et al.  Morphological Effects of Lipopeptides against Aspergillus fumigatus Correlate with Activities against (1,3)-β-d-Glucan Synthase , 1994, Antimicrobial Agents and Chemotherapy.

[22]  K. Tintelnot,et al.  Antifungal Agents , 2003, Special Topic.

[23]  Scott K. Smith,et al.  Isolation and Structural Determination of Enfumafungin, a Triterpene Glycoside Antifungal Agent That Is a Specific Inhibitor of Glucan Synthesis , 2000 .

[24]  J. Smith,et al.  Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis , 1997, Antimicrobial agents and chemotherapy.

[25]  F. Vicente,et al.  Endophytic fungi from plants living on gypsum soils as a source of secondary metabolites with antimicrobial activity , 1998 .

[26]  E. Monte,et al.  ITS sequencing support for Epicoccum nigrum and Phoma epicoccina being the same biological species. , 2000 .

[27]  J. Felsenstein.  CONFIDENCE LIMITS ON PHYLOGENIES: AN APPROACH USING THE BOOTSTRAP , 1985, Evolution; international journal of organic evolution.